Crossmark

Identification and external validation of a prognostic signature based on N6-methyladenosine- and tertiary lymphoid structures-related genes to evaluate survival prognosis and treatment efficacy in lung adenocarcinoma

Crossref DOI link: https://doi.org/10.1007/s12672-025-04318-w

Published Online: 2025-12-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Xiangbao

Zheng, Chengwen

Pan, Yinpeng

Wu, Shuoming
Funding

Funding for this research was provided by:

Health Science and Technology Project of Lianyungang City (202308)
License Information

Text and Data Mining valid from 2025-12-22

Version of Record valid from 2025-12-29
More Information

Article History

Received: 5 September 2025

Accepted: 16 December 2025

First Online: 22 December 2025

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: For this type of study formal consent is not required.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below